Buscar
Mostrando ítems 1-10 de 15
Hepatitis Delta Estimates in the United States Revisited
(Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019-10-30)
To the Editor—We read with interest the article by Patel and colleagues [1], which reported an unexpected 33% prevalence of anti–hepatitis delta virus antibodies (anti-HDV-Abs) in a large and representative US household ...
HTLV-1 infection in solid organ transplant donors and recipients in Spain
(BMC Invectious Diseases, 2019-08-09)
Background: HTLV-1 infection is a neglected disease, despite infecting 10-15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated ...
Jerome Lejeune passed away 25 years ago
(Hereditas, 2019-06-06)
During the past 60 years, modern genetics has steadily evolved from diagnostics to therapeutics. However, treatment of genetic disorders is still in its infancy, with the advent of genome editing as its greatest promise.
Why Not an Opioid Epidemic in Europe Like in the USA?
(AIDS Reviews, 2019-12)
The CDC reported 70,237 drug overdose deaths in the United States in 2017 (Scholl et al., MMWR 2018; 67: 1419-27). Sadly, this yearly rate has been increasing significantly during the past two decades. Opioids, mostly ...
Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain
(Open Forum Infectious Diseases, 2019-02)
Background. Although only 8%-10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late ...
HIV co-infection in HTLV-1 carriers in Spain
(Virus Research, 2019-06)
Background: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. ...
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
(Journal of Antimicrobial Chemotherapy, 2019-05)
Background: HIV-2 is a neglected virus despite estimates of 1-2 million people being infected worldwide. The virus is naturally resistant to some antiretrovirals used to treat HIV-1 and therapeutic options are limited for ...
Sexually Transmitted Infections in Men having Sex with Men - Rising Numbers and Wider Etiologies
(AIDS Reviews, 2019-01)
Classical sexually transmitted infections (STI), namely, syphilis, gonorrhea, trichomonas, and chlamydia, are on the rise worldwide.
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus
(Open Forum Infectious Diseases, 2019-03)
Background. Little is known about the influence of ongoing barriers to care in the persistence of hepatitis C virus (HCV) viremia after treatment with direct-acting antivirals (DAAs) among people living with human ...
Gene editing for HIV cure at the edge
(AIDS Reviews, 2019-01)
Whereas advances in antiretroviral therapy and its widespread use are providing huge benefits in terms of prventing new HIV transmissions to uninfected individuals as well as halting disease progression in patients, the ...